News

QualTex Laboratories, a subsidiary of BioBridge, offers a variety of ways for you to stay connected with us and our subsidiaries. You can read our latest press releases or Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the social media enthusiast, the BioBridge family is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also, visit our blog here.

Media is welcome to contact the Corporate Communications Department for more information.

We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility

Please contact;
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org

Recent News Articles

BCA’s evaluation process aims to reduce costs for member centers
March 2, 2015

After a rigorous evaluation process that included criteria such as quality processes, customer service, pricing and long-term strategy, Blood Centers of America (BCA) has selected QualTex Laboratories as its vendor of choice for member centers’ testing needs.

BCA, which comprises more than 50 independent blood centers and represents more than 40 percent of the U.S. blood supply, made the announcement at its recent member meeting.

BioBridge Global takes part by drawing and testing blood of survivor
February 27, 2015

A team from BioBridge Global’s South Texas Blood & Tissue Center successfully drew a unit of blood Thursday, Feb. 26, from Dr. Akinniyi Emmanuel Fadipe, a Nigerian doctor who survived the Ebola virus. He was drawn at research firm XBiotech in Austin, and they will use it to continue their search for a treatment for those afflicted with the devastating virus.

BioBridge Global is first stop in part of research project
February 23, 2015
Nigerian doctor and Ebola survivor travels to San Antonio to give blood sample

A Nigerian doctor who survived the Ebola virus visited BioBridge Global in San Antonio on Feb. 24 to donate a blood sample and possibly participate in research aimed at treating victims of the devastating disease.

A team from the South Texas Blood & Tissue Center will draw the blood of Dr. Akinniyi Emmanuel Fadipe of Nigeria, and sister affiliate QualTex Laboratories screened the sample to see if he qualifies for a research project underway at Austin-based biotechnology firm XBiotech. STBTC and QualTex are subsidiaries of BioBridge Global.

South Texas Blood & Tissue Center draws blood of Ebola survivor
January 21, 2015

BioBridge Global (BBG) is helping make history in partnership with XBioTech, an Austin bioscience firm searching for a treatment for Ebola

A team from South Texas Blood & Tissue Center (STBTC), which is now part of BBG, drew the blood of Ebola survivor Amber Vinson, a Dallas nurse who was infected with the virus in October while treating a man with the disease last fall. She has since recovered and is no longer contagious.

“We are thrilled to help our partner in this endeavor,” said Dr. Rachel Beddard, BBG medical director. “We have the means to provide raw materials for biomedical research, and we’ve been a partner of this firm for more than four years. We’re proud to be part of research that can make a difference worldwide.”

Dr. Norman D. Kalmin helped steer nonprofit into the future
December 11, 2014

Norman D. Kalmin, M.D., who joined the South Texas Regional Blood Bank (STRBB) in 1983 and shaped it into the community pillar called the South Texas Blood & Tissue Center (STBTC), is set to retire in December after 31 years.

Under Kalmin’s guidance, the organization changed its name, moved to its current headquarters, expanded into tissue and biologic testing services, supported the efforts of the National Marrow Donor Program, added an umbilical cord blood bank and initiated the nonprofit subsidiary QualTex Laboratories.

“This has been the journey of a lifetime,” Kalmin said. “I’m honored to have been part of growing this company and harnessing its potential in the healthcare industry. Together with a very supportive board and skilled management staff, I was able steer it in a direction I hoped would maximize its impact, and I couldn’t be more pleased with the result.”

Pages